Unusual Findings in Trials Evaluating Adjuncts to Scaling and Root Planing: Meta-analysis (Part 1).

antibacterial agents periodontal attachment loss periodontal debridement periodontal pocket periodontitis systematic review

Journal

JDR clinical and translational research
ISSN: 2380-0852
Titre abrégé: JDR Clin Trans Res
Pays: United States
ID NLM: 101684997

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 6 10 2021
medline: 18 6 2022
entrez: 5 10 2021
Statut: ppublish

Résumé

A number of studies in patients with periodontitis have compared scaling and root planning (SRP) combined with an adjunctive treatment to SRP alone. Within that literature, an array of studies with overlapping investigators has consistently yielded substantially greater effects of adjunctive treatments than had been previously noted. This report investigates discrepancies between that cluster of research and the most recent American Dental Association (ADA) systematic review. This review was preregistered at https://osf.io/4meyd/. A search using the Scopus platform identified 32 articles published from 2010 to 2017 by investigators affiliated with the Government Dental College and Research Institute (GDCRI) in Bangalore, India. The primary outcome used in this meta-analysis was the change in clinical attachment level (CAL) after 6 mo. Effect sizes were estimated using Comprehensive Meta-Analysis software after categorizing agents into groups based on pharmacologic similarity. The search identified 32 studies encompassing 5 sets of adjunctive agents. Across the GDCRI studies, the CAL averaged 1.67 mm (95% confidence interval [CI]: 1.43-1.91 mm), substantially exceeding values reported in the ADA review (mean: 0.39 mm, 95% CI: 0.27-0.51 mm). For categories of studies in which comparable subgroup estimates were available, the evaluations yielded overlapping estimates of SRP alone, but CAL estimates were discrepant for both locally delivered antimicrobials (GDCRI studies: mean: 1.45 mm, 95% CI: 0.63-2.27 mm; ADA review: mean: 0.38 mm, 95% CI: 0.16 -0.60 mm) and systemic antibiotics (GDCRI studies: mean: 1.35 mm, 95% CI: 0.97-1.73 mm; ADA review: mean: 0.39 mm, 95% CI: 0.21-0.57 mm). In the literature on adjunctive agents supplementing SRP, findings from investigators linked to GDCRI stand out as having significantly more favorable estimated effects. Meanwhile, some agents studied by GDCRI-linked investigators have not been investigated by other researchers. In the absence of a clear explanation for discrepant results, it is recommended that unusually favorable reported effects of adjunctive agents be viewed with caution. The present meta-analysis observed an unusually large effect size of adjunctive agents to scaling and root planning in studies conducted by the same research group. These results were not consistent with trials on adjunctive agents and previous reports. As this research group has exclusively tested most of the agents, their results must be viewed with caution until other independent groups replicate the studies and reproduce the effect size.

Sections du résumé

BACKGROUND
A number of studies in patients with periodontitis have compared scaling and root planning (SRP) combined with an adjunctive treatment to SRP alone. Within that literature, an array of studies with overlapping investigators has consistently yielded substantially greater effects of adjunctive treatments than had been previously noted. This report investigates discrepancies between that cluster of research and the most recent American Dental Association (ADA) systematic review.
METHODS
This review was preregistered at https://osf.io/4meyd/. A search using the Scopus platform identified 32 articles published from 2010 to 2017 by investigators affiliated with the Government Dental College and Research Institute (GDCRI) in Bangalore, India. The primary outcome used in this meta-analysis was the change in clinical attachment level (CAL) after 6 mo. Effect sizes were estimated using Comprehensive Meta-Analysis software after categorizing agents into groups based on pharmacologic similarity.
RESULTS
The search identified 32 studies encompassing 5 sets of adjunctive agents. Across the GDCRI studies, the CAL averaged 1.67 mm (95% confidence interval [CI]: 1.43-1.91 mm), substantially exceeding values reported in the ADA review (mean: 0.39 mm, 95% CI: 0.27-0.51 mm). For categories of studies in which comparable subgroup estimates were available, the evaluations yielded overlapping estimates of SRP alone, but CAL estimates were discrepant for both locally delivered antimicrobials (GDCRI studies: mean: 1.45 mm, 95% CI: 0.63-2.27 mm; ADA review: mean: 0.38 mm, 95% CI: 0.16 -0.60 mm) and systemic antibiotics (GDCRI studies: mean: 1.35 mm, 95% CI: 0.97-1.73 mm; ADA review: mean: 0.39 mm, 95% CI: 0.21-0.57 mm).
CONCLUSION
In the literature on adjunctive agents supplementing SRP, findings from investigators linked to GDCRI stand out as having significantly more favorable estimated effects. Meanwhile, some agents studied by GDCRI-linked investigators have not been investigated by other researchers. In the absence of a clear explanation for discrepant results, it is recommended that unusually favorable reported effects of adjunctive agents be viewed with caution.
KNOWLEDGE TRANSFER STATEMENT
The present meta-analysis observed an unusually large effect size of adjunctive agents to scaling and root planning in studies conducted by the same research group. These results were not consistent with trials on adjunctive agents and previous reports. As this research group has exclusively tested most of the agents, their results must be viewed with caution until other independent groups replicate the studies and reproduce the effect size.

Identifiants

pubmed: 34609240
doi: 10.1177/23800844211039722
pmc: PMC9207337
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Meta-Analysis Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-241

Subventions

Organisme : NIDCR NIH HHS
ID : R34 DE027410
Pays : United States

Références

J Periodontol. 2016 Mar;87(3):268-74
pubmed: 26447752
J Investig Clin Dent. 2017 May;8(2):
pubmed: 26988864
J Periodontol. 2017 Dec;88(12):1281-1287
pubmed: 22655911
J Periodontol. 2016 Nov;87(11):1278-1285
pubmed: 27442085
J Int Acad Periodontol. 2014 Jul;16(3):67-77
pubmed: 25654959
J Int Acad Periodontol. 2015 Apr;17(2):42-8
pubmed: 26242010
Aust Dent J. 2013 Mar;58(1):34-40
pubmed: 23441790
J Investig Clin Dent. 2017 Aug;8(3):
pubmed: 27091596
J Investig Clin Dent. 2012 Nov;3(4):276-83
pubmed: 22976782
J Periodontol. 2012 Sep;83(9):1155-63
pubmed: 22248223
J Am Dent Assoc. 2015 Jul;146(7):508-24.e5
pubmed: 26113099
J Investig Clin Dent. 2016 Aug;7(3):239-45
pubmed: 25787121
J Periodontol. 2013 Jul;84(7):871-9
pubmed: 23030241
J Periodontol. 2013 Aug;84(8):1165-71
pubmed: 23130655
J Investig Clin Dent. 2015 Aug;6(3):170-8
pubmed: 24574052
J Periodontol. 2016 Jul;87(7):756-62
pubmed: 26878748
J Periodontol. 2012 Oct;83(10):1322-8
pubmed: 22264208
Int J Periodontics Restorative Dent. 2017 Mar/Apr;37(2):e135-e141
pubmed: 28196160
J Periodontal Res. 2018 Feb;53(1):12-21
pubmed: 28872188
J Periodontol. 1999 May;70(5):490-503
pubmed: 10368053
J Periodontol. 2012 Jan;83(1):11-8
pubmed: 21542734
Br J Clin Pharmacol. 2015 Jun;79(6):877-85
pubmed: 25444240
Aust Dent J. 2013 Jun;58(2):156-62
pubmed: 23713634
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Int J Surg. 2012;10(1):28-55
pubmed: 22036893
J Periodontol. 1998 Sep;69(9):989-97
pubmed: 9776027
J Investig Clin Dent. 2016 Feb;7(1):72-80
pubmed: 25044531
Clin Oral Investig. 2018 Mar;22(2):671-687
pubmed: 29396642
J Investig Clin Dent. 2018 Feb;9(1):
pubmed: 28474437
Nat Hum Behav. 2017 Jan 10;1:0021
pubmed: 33954258
J Periodontol. 2015 Jun;86(6):738-45
pubmed: 25786565
J Am Dent Assoc. 2015 Jul;146(7):525-35
pubmed: 26113100
J Periodontol. 2012 Jan;83(1):19-26
pubmed: 21609254
J Int Acad Periodontol. 2013 Apr;15(2):43-50
pubmed: 23705535
J Dent Res Dent Clin Dent Prospects. 2017 Winter;11(1):18-25
pubmed: 28413591
J Clin Periodontol. 2017 Jun;44(6):603-611
pubmed: 28370333
Am J Dent. 2015 Jun;28(3):137-42
pubmed: 26201224
J Periodontol. 2013 Feb;84(2):212-20
pubmed: 22509750
J Periodontal Res. 2018 Jun;53(3):267-287
pubmed: 29211309
J Periodontol. 2012 Sep;83(9):1149-54
pubmed: 22220772
J Periodontol. 2013 Jan;84(1):24-31
pubmed: 22420871
J Periodontol. 2001 Nov;72(11):1535-44
pubmed: 11759865
J Periodontol. 2017 Oct;88(10):1023-1029
pubmed: 28731373
J Appl Oral Sci. 2017 May-Jun;25(3):243-249
pubmed: 28678942
Contemp Clin Dent. 2015 Jul-Sep;6(3):364-70
pubmed: 26321836
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

J C Gunsolley (JC)

Department of Periodontics, Virginia Commonwealth University School of Dentistry, Richmond, VA, USA.

K Al-Abedalla (K)

Division of Periodontology, School of Dental Medicine, UCONN Health, Farmington, CT, USA.

M Shaqman (M)

Department of Oral and Maxillofacial Surgery, Oral Medicine and Periodontology, School of Dentistry, The University of Jordan, Amman, Jordan.

E Ioannidou (E)

Division of Periodontology, School of Dental Medicine, UCONN Health, Farmington, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH